CHICAGO, May 17, 2024
/PRNewswire/ -- 3D Bioprinting Market in terms of
revenue was estimated to be worth $1.3
billion in 2024 and is poised to reach $2.4 billion by 2029, growing at a CAGR of 12.7%
from 2024 to 2029 according to a new report by
MarketsandMarkets™.
The growth in the 3D bioprinting market is fueled by growing
adoption of 3D bioprinting technology within the pharmaceutical and
cosmetic industries, advancement in the 3D bioprinting technology,
rising public and private partnerships and collaborations,
increasing investments in R&D and the expenditure on medical
devices.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787
Browse in-depth TOC on "3D Bioprinting Market"
530 - Tables
46 - Figures
453 -
Pages
3D Bioprinting Market Scope:
Report
Coverage
|
Details
|
Market Revenue in
2024
|
$1.3 billion
|
Estimated Value by
2029
|
$2.4 billion
|
Growth Rate
|
Poised to grow at a
CAGR of 12.7%
|
Market Size Available
for
|
2022–2029
|
Forecast
Period
|
2024–2029
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
By Component, By
Material, By Application, By End User
|
Geographies
Covered
|
North America, Europe,
Asia Pacific, Latin America, Middle East and Africa
|
Report
Highlights
|
Updated financial
information / product portfolio of players
|
Key Market
Opportunities
|
Rising demand for organ
transplants
|
Key Market
Drivers
|
Growing adoption of 3D
bioprinting technology within the pharmaceutical and cosmetic
industries
|
The 3D Bioprinters segment segment is expected to have the
dominant share of the 3D bioprinting market in 2023.
Based on component, the global 3D bioprinting market is
segmented into 3D bioprinters, bioinks, software and consumables.
3D bioprinters accounted for the larger market share in 2023. The
segment is witnessing growth driven by technological innovations
and escalating demand for organ transplantation services.
The Research applications segment is expected to account for
the largest share of the application segment in the 3D bioprinting
market in 2023.
Based on application, the 3D bioprinting market is segmented
into research applications and clinical applications. research
applications segment accounted for the larger share of the 3D
bioprinting market in 2023. The market for research applications is
further segmented into drug research, regenerative medicine, and 3D
cell culture. Among these, the drug research segment accounted for
the largest share of the market during forecast period of
2024-2029, due to the pharmaceutical & biotechnology firms
intensifying their integration of 3D bioprinting technology.
The Asia Pacific region is
anticipated to grow at significant CAGR during the forecast
period.
The Asia Pacific is accounted
to be the fastest-growing segment of the market. Large population
base and robust domestic manufacturing capabilities for systems,
fostering heightened partnerships and collaborations geared towards
healthcare enhancement characterized by substantial investment in
research and development (R&D), rising demand for organ
transplants, rising government funding for advancement of 3D
bioprinting technology in the region. Additionally, notable surge
in stem cell research activities across several APAC
countries, further contributing to the biomedical landscape is
driving 3D bioprinting uptake in the region.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=170201787
3D Bioprinting Market Dynamics:
Drivers:
1. Growing adoption of 3D bioprinting technology within
the pharmaceutical and cosmetic industries
Restraints:
1. High cost of 3D bioprinters and bioinks
Opportunities:
1. Rising demand for organ transplants
Challenge:
1. Biocompatibility issues and rigorous sterilization
protocols
Key Market Players of 3D Bioprinting
Industry:
BICO Group AB (US), 3D Systems, Inc. (US), Merck KGaA
(Germany), Organovo Holings Inc
(US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), Aspect Biosystem Ltd.
(Canada), Advanced Solutions Life
Sciences, LLC (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare Inc. (South Korea), Hangzhou Genofei Biotechnology
Co., Ltd. (China), Foldink
(Armenia), Brinter (US) and 3D
bioprinting solution (Russia) and
REGEMAT 3D, SL (Spain) are some of
the leading players in this market. Most companies in the market
focus on organic and inorganic growth strategies, such as product
launches, expansions, acquisitions, partnerships, agreements, and
collaborations, to increase their product offerings, cater to the
unmet needs of customers, increase their profitability, and expand
their presence in the global market.
The primary interviews conducted for this report can be
categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs &
Directors - 30%, Executives- 25%
- By Region: North America -40%,
Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East-and Africa -5%
Recent Developments of 3D Bioprinting Industry:
- In February 2024, BICO Group AB
(Cellink) launched DNA Studio 4 Vault, a bioprinting software,
providing users with confidence and trust in their documentation,
enabling a faster translation from the research lab to the
clinic
- In February 2024, Merck KGaA
(Germany) established a
distribution center in Brazil with
an investment of USD 21.7 million to
better serve its Life Science customers for faster deliveries in
the region.
- In April 2023, Aspect Biosystem
Ltd (Canada) and Novo Nordisk
(Denmark) entered into a
collaboration, development, and Licence agreement to develop
bioprinted tissue therapeutics designed to replace, repair, or
supplement biological functions inside the body to deliver a new
class of truly disease-modifying treatments for diabetes and
obesity.
- In April 2023, CollPlant
Biotechnologies Ltd (Israel) and
Stratasys (US) entered into a collaboration for the development of
collaborated to develop a solution to bio-fabricate human tissues
and organs using Stratasys' P3 technology-based bioprinter and
CollPlant's rh-Collagen-based bioinks
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787
3D Bioprinting Market - Key Benefits of Buying the
Report:
The report will help market leaders/new entrants by providing
them with the closest approximations of the revenue numbers for the
overall 3D bioprinting market and its subsegments. It will also
help stakeholders better understand the competitive landscape and
gain more insights to better position their business and make
suitable go-to-market strategies. This report will enable
stakeholders to understand the market's pulse and provide them with
information on the key market drivers, restraints, opportunities,
and challenges.
The report provides insights on the following
pointers:
- Analysis of key drivers (growing adoption of 3D bioprinting
technology in the pharmaceutical and cosmetic industries,
technological advancement in the 3D bioprinting , increasing number
of public-private partnerships, rising investments in R&D and
medical devices), opportunities (Rising demand for organ
transplants and growing demand for regenerative medicine and stem
cell research) and challenges (biocompatibility issues and rigorous
sterilization protocols and ethical concerns related to the use of
3D bioprinted products) are influencing the growth of 3D
bioprinting market.
- Product Development/Innovation: Detailed insights on newly
launched products of the 3D bioprinting market.
- Market Development: Comprehensive information about lucrative
markets – the report analyses the 3D bioprinting market across
varied regions.
- Market Diversification: Exhaustive information about new
services, untapped geographies, recent developments, and
investments in the 3D bioprinting market.
- Competitive Assessment: In-depth assessment of market shares,
growth strategies, and service offerings of leading players include
BICO Group AB (Sweden), 3D Systems
Inc. (US), Merck KGaA (Germany),
Organovo Holdings Inc (US), Collplant Biotechnologies Ltd
(Israel), regenHU (Switzerland), Aspect Biosystem (Canada), Advanced Solutions Life Sciences, llc
(US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare (South Korea), Hangzhou Genofei Biotechnology
Co., Ltd. (China), Foldink
(Armenia), Brinter (US) and 3D
bioprinting solution (Russia).
Related Reports:
Biomaterials Market - Global Forecasts to 2029
In Vitro Diagnostics Market - Global Forecasts to
2029
3D Cell Culture Market - Global Forecasts to
2028
3D Printing Medical Devices Market - Global
Forecasts to 2028
4D Printing in Healthcare Market - Global Forecasts
to 2026
Get access to the latest updates on 3D Bioprinting
Companies and 3D Bioprinting Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/3d-bioprinting-market-worth-2-4-billion--marketsandmarkets-302148746.html
SOURCE MarketsandMarkets